More power for drug development in Japan!

Utilizing information technology in drug development and contributing to people's happiness

Realize true DX

Carefully selected solutions

Global level support

Services
Partners
Global

What's new

Apr. 17, 2026 - Trademark registration in Japan completed for “Magoneko” and the Paw logo

Apr. 10, 2026 - Notice Regarding Accounts Impersonating Our Employees or Executives on LinkedIn

Mar. 11, 2026 - EHR Integration and Solution Seminar by Akyrian Systems

For more than 20 years, it has been said that the pharmaceutical industry in Japan has been slow to adopt IT, and the same holds true for DX at this time. We support the realization of true Digital Transformation through consulting on the utilization of IT and AI.
There are many solutions that are widely used overseas, but not in Japan. We will carefully select these, implement them, build a support system, and provide services in Japan.
This will accelerate drug development in Japan.
By utilizing the relationships we have cultivated with star players who are active globally and incorporating their methods, we support the resolution of various issues in drug development in Japan.